WindRose Health Investors Commits $85 Million in Financing to Kidney Health Management Company Healthmap Solutions
WindRose Health Investors has recapitalized Healthmap Solutions with a commitment of $85 million to continue national expansion of its kidney health management services. As featured in Agility PR.
Tampa, FL – Kidney health management industry leader Healthmap Solutions Inc. (“Healthmap” or the “Company”) announced today that WindRose Health Investors, LLC (“WindRose”), a New York-based healthcare private equity firm, has recapitalized the Company with a commitment of $85 million. Healthmap plans to use the funds to continue national expansion of its kidney health management services, and to support its unique model of assuming risk for reducing the cost of care for those with complex kidney health conditions.
Better support for every step of complex care
Healthmap brings population health management, kidney and cardiac care, technology and analytics, and care navigation together to help health plans and providers support the people they serve with greater clarity and coordination.